S. Camilleribroet et al., AIDS-RELATED PRIMARY BRAIN LYMPHOMAS - HISTOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY OF 51 CASES, Human pathology, 28(3), 1997, pp. 367-374
Fifty-one cases of acquired immunodeficiency syndrome (AIDS)-related p
rimary brain lymphomas (AR-PBL) ere investigated for clinical characte
ristics; human immunodeficiency virus (HIV)-associated disorders; hist
opathologic features; immunophenotype; Epstein-Barr virus (EBV) infect
ion; and, when frozen tissue was available, oncogene rearrangements. A
R-PBL occurred late in the course of AIDS and were usually associated
with other systemic or cerebral disorders and with a low level of CD4
lymphocytes. All cases were high grade lymphomas according to the Work
ing Formulation or updated Kiel classification, and often displayed a
multifocal pattern. Thirty cases were classified as immunoblastic with
plasmacytic differentiation, 18 cases were large cell lymphomas with
an immunoblastic component or centroblastic polymorphic lymphomas, and
2 were small noncleaved non-Burkitt lymphomas (Working Formulation).
This latter category is classified as Burkitt's-like lymphoma in the R
EAL nomenclature. One case could not be classified because of necrosis
. AR-PBL showed a high level expression of activation and adhesion mol
ecules. The presence of EBV was detected in most cases, and, when PCR
was used, this was a constant finding. bcl-2 oncoprotein and latent me
mbrane protein-1 (LMP-1) were strongly expressed. None of the tested c
ases expressed p53, or were rearranged for bcl-2 or c-myc oncogenes. T
his study confirms the immunophenotypic specificity of AR-PEL, which m
ay reflect the special immune status of the brain. Copyright (C) 1997
by W.B. Saunders Company.